JOENSUU, Finland, Aug. 15, 2019 /PRNewswire/ -- A new study by researchers at the University of Eastern Finland is the first to observe that dietary intake of phosphatidylcholine is associated with a reduced risk of dementia. Phosphatidylcholine was also linked to enhanced cognitive performance. The main dietary sources of phosphatidylcho

WINDSOR LOCKS, Conn., Aug. 15, 2019 /PRNewswire/ -- This weekend S.M.A.R.T. is having a conference August 17 - 18, 2019 in Connecticut. https://ritualabuse.us/smart-conference/ Alison Miller, Ph.D. is a retired clinical psychologist who practiced in

WASHINGTON, Aug. 15, 2019 /PRNewswire/ -- A large majority of adults in the United States are stressed by mass shootings, and a third of U.S. adults say that fear of mass shootings stops them from going to certain places and events, according to a new survey on stress and mass shootings by the American Psychological Associ

ROSEMONT, Ill., Aug. 15, 2019 /PRNewswire/ -- A wrong twist, rotation or roll could cause a broken ankle, also known as an ankle fracture, among people of all ages. One or more broken bones in an ankle joint can lead to instability and an active, older population of "baby boomers" have been seeing an increase in the number and severity of broken ankles. Among M

DALLAS and LOUISVILLE, Ky., Aug. 14, 2019 /PRNewswire/ -- ADVault, Inc., and leading health and well-being company Humana Inc., today announced a significant expansion of the digi

DENVER, Aug. 14, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company"), today provided the financial results for its second quarter of 2019.

NEW YORK, Aug. 14, 2019 /PRNewswire/ -- Inc. magazine today revealed that LoveBug Probiotics ranked No. 140 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies. In addition, LoveBug Probiotics was featured in the top 500 companies. The list represents a unique look at the most successful compan

HONOLULU, Aug. 14, 2019 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) today filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019.Recent developments include:CHASE Clinical Trial UpdateCardax plans a pre-specified interim review in September 2019 of the a

HONOLULU, Aug. 14, 2019 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced today that it filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed follow-on public offering of up to $15 million of the Company's common stock and warrants. The number of securities to be offered and the price

Adjusted EBITDA up more than $5M (CDN) versus prior quarter;Company positioned to bring CBD products to U.S. market by end of fiscal 2020;Record harvest of over 40,000 kgKEY HIGHLIGHTSGenerated net revenue1 of $90.5 million in Q1 2020. Adjusted EBITDA of